Titre:
  • Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.
Auteur:Langleben, David; Christman, Brian W; Barst, Robyn J.; Dias, Virgil C; Galie, Nazzareno; Higenbottam, Timothy; Kneussl, Meinhard; Korducki, Larry; Naeije, Robert; Riedel, Axel; Simonneau, Gerald; Hirsch, Andrew M; Rich, Stuart; Robbins, Ivan M.; Oudiz, Ronald J.; McGoon, Michael; Badesch, David B.; Levy, Robert D; Mehta, Sanjay; Seeger, Werner; Solèr, Markus
Informations sur la publication:The American heart journal, 143, 5, page (E4)
Statut de publication:Publié, 2002-05
Sujet CREF:Physiologie générale
MeSH keywords:Walking
Note générale:Clinical Trial
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0002-8703
info:pii/S0002870302839151
info:pmid/12040360